BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10359123)

  • 1. Inhibitory effects of the Trypanosoma cruzi membrane glycoprotein AGC10 on the expression of IL-2 receptor chains and secretion of cytokines by subpopulations of activated human T lymphocytes.
    Kierszenbaum F; de Diego JL; Fresno M; Sztein MB
    Eur J Immunol; 1999 May; 29(5):1684-91. PubMed ID: 10359123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Trypanosoma cruzi membrane glycoprotein AGC10 inhibits human lymphocyte activation by a mechanism preceding translation of both, interleukin-2 and its high-affinity receptor subunits.
    Kierszenbaum F; Fresno M; Sztein MB
    Mol Biochem Parasitol; 2002; 125(1-2):91-101. PubMed ID: 12467977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of human B lymphocyte activities by a Trypanosoma cruzi membrane glycoprotein.
    Kierszenbaum F; Sztein MB
    Int J Parasitol; 2001 Mar; 31(3):265-71. PubMed ID: 11226453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of Trypanosoma cruzi-induced immunosuppression. Altered expression by activated human lymphocytes of molecules which regulate antigen recognition and progression through the cell cycle.
    Kierszenbaum F; Moretti E; Sztein MB
    Biol Res; 1993; 26(1-2):197-207. PubMed ID: 7670532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes.
    Sztein MB; Cuna WR; Kierszenbaum F
    J Immunol; 1990 May; 144(9):3558-62. PubMed ID: 2139458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production.
    Van Voorhis WC
    J Immunol; 1992 Jan; 148(1):239-48. PubMed ID: 1727869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Trypanosoma cruzi membrane mucin AgC10 inhibits T cell activation and IL-2 transcription through L-selectin.
    Alcaide P; Fresno M
    Int Immunol; 2004 Oct; 16(10):1365-75. PubMed ID: 15314038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Trypanosoma cruzi-induced down-regulation of lymphocyte function. Inhibition of transcription and expression of IL-2 receptor gamma (p64IL-2R) and beta (p70IL-2R) chain molecules in activated normal human lymphocytes.
    Majumder S; Kierszenbaum F
    J Immunol; 1996 May; 156(10):3866-74. PubMed ID: 8621925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AgC10, a mucin from Trypanosoma cruzi, destabilizes TNF and cyclooxygenase-2 mRNA by inhibiting mitogen-activated protein kinase p38.
    Alcaide P; Fresno M
    Eur J Immunol; 2004 Jun; 34(6):1695-704. PubMed ID: 15162440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mechanism for Trypanosoma cruzi-induced suppression of human lymphocytes. Inhibition of IL-2 receptor expression.
    Beltz LA; Sztein MB; Kierszenbaum F
    J Immunol; 1988 Jul; 141(1):289-94. PubMed ID: 3132504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression by Trypanosoma cruzi of T-cell receptor expression by activated human lymphocytes.
    Sztein MB; Kierszenbaum F
    Immunology; 1992 Oct; 77(2):277-83. PubMed ID: 1427979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma cruzi: the effect of nitric oxide synthesis inhibition on the CD4 T cell response to the trans-sialidase superfamily.
    Millar AE; Kahn SJ
    Exp Parasitol; 2000 Feb; 94(2):84-91. PubMed ID: 10673344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective suppressive effects of Trypanosoma cruzi on activated human lymphocytes.
    Beltz LA; Kierszenbaum F; Sztein MB
    Infect Immun; 1989 Aug; 57(8):2301-5. PubMed ID: 2663720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of Trypanosoma cruzi on the transcription of the p55IL-2R, c-fos, c-myc and CD69 genes in activated human lymphocytes.
    Kierszenbaum F; Majumder S; Mejia Lopez H; Sztein MB
    Parasite Immunol; 1995 Apr; 17(4):197-205. PubMed ID: 7624160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus.
    Chang FY; Shaio MF
    Diabetes Res Clin Pract; 1995 May; 28(2):137-46. PubMed ID: 7587921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 vs. type 2 cytokine secretion in vitro and its regulation by hydrocortisone in humans subjected to 120-day anti-orthostatic bed-rest regime.
    Uchakin PN; Tobin BW; Morukov BV; Larina IV; Cubbage ML
    J Gravit Physiol; 2002 Dec; 9(2):71-82. PubMed ID: 14638461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of T lymphocyte activation in vitro and in vivo induced by glycoinositolphospholipids from Trypanosoma cruzi. Assignment of the T cell-suppressive determinant to the ceramide domain.
    Gomes NA; Previato JO; Zingales B; Mendonça-Previato L; DosReis GA
    J Immunol; 1996 Jan; 156(2):628-35. PubMed ID: 8543814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations induced by Trypanosoma cruzi in activated mouse lymphocytes.
    Lopez HM; Tanner MK; Kierszenbaum F; Sztein MB
    Parasite Immunol; 1993 May; 15(5):273-80. PubMed ID: 8332383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.